Segmenting by application reveals how telemonitoring creates value across the care continuum. Cardiovascular programmes currently hold the greatest share, driven by CMS-covered RPM codes for hypertension and arrhythmia, translating into measurable readmission reductions. Diabetes solutions follow, leveraging reimbursed glucometer-to-cloud pathways and demonstrating HbA1c improvements of 0.8–1.0 %. Respiratory monitoring captured exponential growth post-COVID-19, with pulse-oximetry-based early-warning systems adopted by >70 % of U.S. health systems. Mental-health and chronic-pain modules, though smaller, exhibit 30 %+ CAGR as behavioural health parity laws and digital therapeutic billing expand. Finally, post-operative and cancer-care bundles round out the taxonomy, reducing travel burden and infection exposure. Together, these application segments delineate a market moving from one-size-fits-all devices to condition-specific data streams, anchoring sustainable revenue models for Healthcare Telemonitoring System vendors.